<DOC>
	<DOC>NCT00607256</DOC>
	<brief_summary>To evaluate the lon-term safety and tolerability of [S,S]-reboxetine in patients with fibromyalgia</brief_summary>
	<brief_title>Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Diagnosis of patients meeting the ACR criteria for fibromyalgia (i.e. widespread pain present for at least 3 months, and pain in at least 11 of 18 specific tender point sites) Patients with other severe pain (e.g. DPN and PHN) that may confound assessment or selfevaluation of the pain associated with fibromyalgia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>